117 related articles for article (PubMed ID: 7572138)
1. Collagen IV and tenascin immunoreactivity as prognostic determinant in benign and malignant salivary gland tumours.
Kärjä V; Syrjänen K; Syrjänen S
Acta Otolaryngol; 1995 Jul; 115(4):569-75. PubMed ID: 7572138
[TBL] [Abstract][Full Text] [Related]
2. Tenascin in salivary gland tumours.
Soini Y; Pääkkö P; Virtanen I; Lehto VP
Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):217-22. PubMed ID: 1384222
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells.
Shrestha P; Sumitomo S; Ogata K; Yamada K; Takai Y; Yang L; Mori M
Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):393-9. PubMed ID: 7536507
[TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 oncogene expression in salivary gland tumours.
Kärjä V; Syrjänen S; Kataja V; Syrjänen K
ORL J Otorhinolaryngol Relat Spec; 1994; 56(4):206-12. PubMed ID: 7915830
[TBL] [Abstract][Full Text] [Related]
5. Basal membrane associated substances in human salivary glands and salivary gland tumours.
Caselitz J; Schmitt P; Seifert G; Wustrow J; Schuppan D
Pathol Res Pract; 1988 Aug; 183(4):386-94. PubMed ID: 2847123
[TBL] [Abstract][Full Text] [Related]
6. Basement membrane proteins in salivary gland tumours. Distribution of type IV collagen and laminin.
Skalova A; Leivo I
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):425-31. PubMed ID: 1375797
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of non-malignant salivary gland tumours based on 675 cases].
Wierzbicka M; Kopeć T; Szyfter W; Bem G
Otolaryngol Pol; 2010; 64(5):281-7. PubMed ID: 21166137
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas.
Sunardhi-Widyaputra S; Van Damme B
Pathol Res Pract; 1993 Mar; 189(2):138-43. PubMed ID: 7686669
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of ALDH-1 is associated with clinical parameters of salivary glands neoplasms.
da Silva LP; Lopes MLDS; Sarmento ASC; de Albuquerque Borges M; de Moura SRS; Sobral APV; de Souza LB
Exp Mol Pathol; 2020 Dec; 117():104552. PubMed ID: 33053323
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
[TBL] [Abstract][Full Text] [Related]
11. Immunocompetent cells in benign and malignant salivary gland tumors.
Kärjä VJ; Syrjänen KJ; Syrjänen SM
Gen Diagn Pathol; 1996 Oct; 142(2):75-81. PubMed ID: 8950571
[TBL] [Abstract][Full Text] [Related]
12. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
Aljorani LE; Bankfalvi A; Carey FA; Harada K; Ohe G; Jones SJ; Ellis IR; Schor SL; Schor AM
J Oral Pathol Med; 2011 Nov; 40(10):747-54. PubMed ID: 21481007
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and degradation of basement membranes in benign and malignant salivary gland tumours. A study by in situ hybridization.
Soini Y; Autio-Harmainen H
J Pathol; 1993 Jul; 170(3):291-6. PubMed ID: 8133403
[TBL] [Abstract][Full Text] [Related]
14. Nuclear hBD-1 accumulation in malignant salivary gland tumours.
Wenghoefer M; Pantelis A; Dommisch H; Götz W; Reich R; Bergé S; Martini M; Allam JP; Jepsen S; Merkelbach-Bruse S; Fischer HP; Novak N; Winter J
BMC Cancer; 2008 Oct; 8():290. PubMed ID: 18840281
[TBL] [Abstract][Full Text] [Related]
15. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Salmas M; Malamou-Mitsi V
BJU Int; 2005 Mar; 95(4):655-9. PubMed ID: 15705098
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
17. Expression of the adenocarcinoma-related antigen recognized by monoclonal antibody 44-3A6 in salivary gland neoplasias.
Bentz BG; Haines GK; vonSchlegell AS; Elseth KM; Hanson DG; Radosevich JA
Otolaryngol Head Neck Surg; 1998 May; 118(5):603-9. PubMed ID: 9591857
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of extracellular matrix proteins in human salivary gland development.
Furuse C; Cury PR; de Araújo NS; de Araújo VC
Eur J Oral Sci; 2004 Dec; 112(6):548-51. PubMed ID: 15560840
[TBL] [Abstract][Full Text] [Related]
19. Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms.
Westernoff TH; Jordan RC; Regezi JA; Ramos DM; Schmidt BL
Oral Oncol; 2005 Feb; 41(2):170-4. PubMed ID: 15695119
[TBL] [Abstract][Full Text] [Related]
20. Distribution of tenascin-C, fibronectin and collagen types III and IV during regeneration of rat submandibular gland.
Ueda K; Shimizu O; Oka S; Saito M; Hide M; Matsumoto M
Int J Oral Maxillofac Surg; 2009 Jan; 38(1):79-84. PubMed ID: 19097859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
